Stay updated on Retroviral Vector and Prodrug for Brain Tumor Surgery Clinical Trial
Sign up to get notified when there's something new on the Retroviral Vector and Prodrug for Brain Tumor Surgery Clinical Trial page.

Latest updates to the Retroviral Vector and Prodrug for Brain Tumor Surgery Clinical Trial page
- Check4 days agoNo Change Detected
- Check11 days agoChange DetectedThe page shows Revision: v3.4.2 replacing v3.4.1, indicating a minor maintenance update that does not alter study information.SummaryDifference0.1%

- Check19 days agoChange DetectedThe revision label on the page was updated from v3.4.0 to v3.4.1, with no changes to the study details or other substantive content. To avoid being alerted by small changes, set an alert condition by clicking below.SummaryDifference0.1%

- Check27 days agoChange DetectedThe page now includes a glossary toggle, a 'Last Update Submitted that Met QC Criteria' line, a 'No FEAR Act Data' notice, and Revision: v3.4.0. The previous items 'Last Update Submitted that met QC Criteria', 'No FEAR Act data', and Revision: v3.3.4 were removed.SummaryDifference0.2%

- Check42 days agoChange DetectedFooter revision updated from v3.3.3 to v3.3.4; this is a minor UI/documentation update. To avoid being alerted by small changes, set an alert condition by clicking below.SummaryDifference0.1%

- Check63 days agoChange DetectedAdded a centralized Locations section listing study sites by state (California, Michigan, New Jersey, Ohio, Washington) and removed the separate state location subsections.SummaryDifference0.6%

- Check92 days agoChange DetectedA note was added clarifying that PubMed-listed publications are automatically filled from PubMed and may not relate to the study, along with an update to the revision tag v3.3.2. To avoid being alerted by small changes, set an alert condition by clicking below.SummaryDifference0.1%

Stay in the know with updates to Retroviral Vector and Prodrug for Brain Tumor Surgery Clinical Trial
Enter your email address, and we'll notify you when there's something new on the Retroviral Vector and Prodrug for Brain Tumor Surgery Clinical Trial page.